These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29437483)

  • 1. Technology and Pregnancy.
    Yamamoto JM; Murphy HR
    Diabetes Technol Ther; 2018 Feb; 20(S1):S94-S103. PubMed ID: 29437483
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of continuous intravenous insulin infusion in type 1 diabetic pregnancy complicated by nephrotic syndrome.
    Dudding S; Whitelaw D
    Diabetes Res Clin Pract; 2011 Jul; 93(1):e53-6. PubMed ID: 21543130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensor augmented pump therapy in the management of type 1 diabetes complicated with Addison's disease prior to and during pregnancy.
    Vinagre I; Giménez M; Pericot A; Bellart J; Conget I
    Endocrinol Nutr; 2014; 61(6):341-3. PubMed ID: 24680974
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange.
    Polsky S; Wu M; Bode BW; DuBose SN; Goland RS; Maahs DM; Foster NC; Peters AL; Levy CJ; Shah VN; Beck RW
    Diabetes Technol Ther; 2018 Aug; 20(8):517-523. PubMed ID: 29990438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New fast-acting insulin analog. This insulin profits type l and type 2 diabetics].
    Wepner U
    MMW Fortschr Med; 2004 Nov; 146(47):62-3. PubMed ID: 15624662
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal-Fetal Outcomes in 34 Pregnant Women with Type 1 Diabetes in Sensor-Augmented Insulin Pump Therapy.
    Gómez AM; Marín Carrillo LF; Arévalo Correa CM; Muñoz Velandia OM; Rondón Sepúlveda MA; Silva Herrera JL; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Jul; 19(7):417-422. PubMed ID: 28731823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advantages of fast-acting insulin analogs: preprandial greater HbA1c lowering -- postprandial lower weight].
    MMW Fortschr Med; 2005 Aug; 147(33-34):45. PubMed ID: 16138637
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of emerging new technologies.
    Garg SK
    Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes Technology and the Human Factor.
    Liberman A; Barnard K
    Diabetes Technol Ther; 2018 Feb; 20(S1):S128-S138. PubMed ID: 29437474
    [No Abstract]   [Full Text] [Related]  

  • 10. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
    [No Abstract]   [Full Text] [Related]  

  • 12. [Postprandial glycemia in diabetes patients: assessing this indicator].
    Letonturier P
    Presse Med; 2006 Dec; 35(12 Pt 1):1855-6. PubMed ID: 17205659
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the basal/bolus ratio on continuous glucose monitoring parameters in patients with type 1 diabetes.
    González-Vidal T; Rivas-Otero D; Ramos-Ruiz G; Agüeria-Cabal P; Lambert C; Ares J; Delgado E; Menéndez-Torre E
    Diabetes Obes Metab; 2024 Aug; 26(8):3482-3485. PubMed ID: 38826106
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased Usage of Insulin Pump Functions Not Associated With Improved HbA1c in Children and Adolescents With Type 1 Diabetes Mellitus.
    Sandberg H; Anderberg P; Forssell H; Ovhed I; Berglund J
    J Diabetes Sci Technol; 2016 Jul; 10(4):997-8. PubMed ID: 26721525
    [No Abstract]   [Full Text] [Related]  

  • 15. Closing the Loop.
    Nimri R; Audon P; Pinsker JE; Dassau E
    Diabetes Technol Ther; 2018 Feb; 20(S1):S41-S54. PubMed ID: 29437478
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin requirements during pregnancy].
    Lorenzini F
    Soins; 2006 Sep; (708):19-20, 22. PubMed ID: 17024993
    [No Abstract]   [Full Text] [Related]  

  • 17. Six-Year Follow-Up After Insulin Pump Initiation: HbA1c Is Significantly Reduced Without Weight Gain.
    Andersen HU; Hangaard S; Hommel E; Ridderstråle M
    J Diabetes Sci Technol; 2018 Mar; 12(2):535-536. PubMed ID: 28927286
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancy.
    Secher AL; Schmidt S; Nørgaard K; Mathiesen ER
    Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1233-7. PubMed ID: 20804351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring intensified insulin therapy in children.
    Danne T
    Pediatr Diabetes; 2009 Aug; 10(5):295-7. PubMed ID: 19682282
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin pump dosing across gestation in women with well-controlled type 1 diabetes mellitus.
    Roeder HA; Moore TR; Ramos GA
    Am J Obstet Gynecol; 2012 Oct; 207(4):324.e1-5. PubMed ID: 23021699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.